Dow Jones

38,868.04

0.18%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

PULM

Pulmatrix (PULM)

Pulmatrix Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PULM

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
30/05/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PULM	Pulmatrix Inc
29/05/2024	07:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PULM	Pulmatrix Inc
17/05/2024	15:06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PULM	Pulmatrix Inc
10/05/2024	08:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	08:21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	08:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PULM	Pulmatrix Inc
30/01/2023	15:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PULM	Pulmatrix Inc
16/05/2022	05:28	TipRanks	H.C. Wainwright Thinks Pulmatrix’s Stock is Going to Recover	NASDAQ:PULM	Pulmatrix Inc
29/04/2022	15:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PULM	Pulmatrix Inc
19/04/2022	15:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	16:23	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	08:21	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PULM	Pulmatrix Inc
14/02/2022	14:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	08:10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	08:00	PR Newswire (US)	Pulmatrix Issues Letter to Stockholders	NASDAQ:PULM	Pulmatrix Inc
17/12/2021	05:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PULM	Pulmatrix Inc
27/07/2021	09:00	PR Newswire (US)	Pulmatrix appoints Director Anand Varadan	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	15:09	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	07:15	TipRanks	Pulmatrix Will Regain Full Rights To PUR1800 After Termination Of Licensing Agreement; Shares Fall 16%	NASDAQ:PULM	Pulmatrix Inc
26/03/2021	15:01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PULM	Pulmatrix Inc
24/02/2021	09:23	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PULM	Pulmatrix Inc
23/02/2021	15:21	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:PULM	Pulmatrix Inc
14/08/2020	05:08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PULM	Pulmatrix Inc
07/08/2020	15:31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:PULM	Pulmatrix Inc
06/07/2020	05:31	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PULM	Pulmatrix Inc
25/06/2020	15:16	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:PULM	Pulmatrix Inc
23/04/2020	13:15	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:PULM	Pulmatrix Inc
18/09/2019	08:30	PR Newswire (US)	Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmo...	NASDAQ:PULM	Pulmatrix Inc
19/08/2019	08:25	PR Newswire (US)	Pulmatrix Receives US Patent Covering iSPERSE™ Formulations for Pulmazole Program	NASDAQ:PULM	Pulmatrix Inc
05/08/2019	08:00	PR Newswire (US)	Pulmatrix Reports Q2 2019 Results	NASDAQ:PULM	Pulmatrix Inc